What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to inform investors about the U.S. Circuit Court of Appeals affirming a lower court's decision to block Anthem's proposed acquisition of Cigna. The company also issued a press release stating its commitment to the deal and its plan to review options.

What was the outcome of the court ruling mentioned?

The U.S. Circuit Court of Appeals for the District of Columbia affirmed the ruling of the U.S. District Court for the District of Columbia, which prevents Anthem from acquiring Cigna.

What is Anthem's (Elevance Health's) stance on the blocked acquisition?

Anthem remains committed to completing the acquisition of Cigna and is actively reviewing the court's opinion to determine its next steps and evaluate available options.

Where can I find more details about the company's response?

Further details can be found in the press release dated April 28, 2017, which is furnished as Exhibit 99.1 to this 8-K filing. The filing also directs investors to previous SEC filings, including the Form S-4 registration statement, for information regarding the proposed transaction.

ELV 8-K SEC Disclosure — Apr 28, 2017

Summary

Elevance Health, Inc. (formerly Anthem, Inc.) filed an 8-K on April 28, 2017, to report on a significant legal development regarding its proposed acquisition of Cigna Corporation. The U.S. Circuit Court of Appeals for the District of Columbia affirmed a lower court's ruling blocking the deal. Despite this setback, the company stated its commitment to completing the acquisition and was reviewing the court's opinion to evaluate its options. This news is critical for investors as it directly impacts the strategic growth and future financial performance that the merger was expected to deliver.

Key Highlights

1Anthem, Inc. (now Elevance Health) announced a legal setback in its proposed acquisition of Cigna Corporation.
2The U.S. Circuit Court of Appeals affirmed a district court's decision to block the acquisition.
3The company expressed its commitment to completing the acquisition despite the court ruling.
4Elevance Health is currently reviewing the court's opinion and evaluating its strategic options.
5This 8-K filing primarily serves to disclose the legal outcome and the company's immediate response.
6The filing references a furnished press release (Exhibit 99.1) for further details on the company's statement.

Elevance Health, Inc. 8-K Report, Corporate Update (Apr 28, 2017)

Summary

Key Highlights

Frequently Asked Questions